Harfst & Associates’s Humana HUM Stock Holding History

Harfst & Associates’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-194	Closed	-$39K	–	255
2017 Q1	$39K	Buy	+194	New	+$40.1K	0.02%	158
2016 Q1	–	Sell	-556	Closed	-$99K	–	141
2015 Q4	$99K	Sell	556 -12	-2%	-$2.11K	0.04%	141
2015 Q3	$102K	Buy	568 +68	+14%	+$12.6K	0.04%	125
2015 Q2	$96K	Buy	+500	New	+$92.8K	0.05%	125

Other funds holding HUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Harfst & Associates's HUM Position: Q2 2017 in Review

Harfst & Associates sold out of Humana (HUM) in Q2 2017, closing a stake of 194 shares — an estimated $39K sold.

Harfst & Associates first reported a position in HUM in Q2 2015 and held it in 4 quarters. The position peaked at $102K in Q3 2015. 636 funds tracked by Wall St. Rank hold HUM as of Q2 2017.

Harfst & Associates reported no remaining Humana position as of Q2 2017 after selling out during the quarter.
Harfst & Associates sold 194 Humana shares in Q2 2017, an estimated $39K.
Harfst & Associates first reported a position in Humana in Q2 2015 and held it in 4 quarters.
Harfst & Associates's Humana position peaked at $102K in Q3 2015.
636 funds tracked by Wall St. Rank held Humana as of Q2 2017.

Based on Harfst & Associates's 13F filing for Q2 2017, filed 11 Aug 2017.